enantiomer

(redirected from enantiomerically)
Also found in: Dictionary, Thesaurus, Encyclopedia.

enantiomer

 [en-an´te-o″mer]
one of a pair of isomeric compounds whose molecular structures are mirror images of each other.

en·an·ti·o·mer

(en-an'tē-ō-mĕr),
One of a pair of molecules that are nonsuperimposable mirror images of each other; neither molecule has an internal plane of symmetry.
Synonym(s): optic antipode
[enantio- + G. meros, part]
References in periodicals archive ?
The results obtained thus demonstrate the usefulness of resolution of racemates and enantiomerically enriched compounds in drug development of antimicrobial agents of coordinated compounds.
All naturally-occurring proteins are enantiomerically pure because the amino acid building blocks that comprise proteins exist as single enantiomers.
They were able to introduce a chiral twist into these materials by inserting an enantiomerically pure (one-handed) chiral monomer, such as indane bisphenol (IBP) or spirobiindane (SBI), into the polymer backbone.
Industrial chemists have also recruited legions of microorganisms and their enzymes to convert raw materials into enantiomerically pure products.
Our further synthetic effort was focused on structural modifications of compound 3, including their enantiomerically enriched forms (Scheme 3).
As is well known, discovery of the existence of enantiomeric isomers of organic compounds as well as their isolation as enantiomerically pure isomers with the use of tweezers under microscope were performed for the preparation of enantiomerically pure D-(-)- and L-(+)-tartaric acids as early as the mid-nineteenth century by L.
Yus, "Microwave-assisted solvent-free synthesis of enantiomerically pure N-(tert-Butylsulfinyl)imines," Journal of Organic Chemistry, vol.
Chiral epoxides are very important building blocks for the synthesis of enantiomerically pure molecules of biologically active compounds and pharmaceuticals [1-3].
Thus, new methods for obtaining optically active sulfoxides are required for the synthesis of enantiomerically enriched compounds.
This assay uses pseudo-prochiral (H5, D5) malonate diesters, which need only be enantiomerically enriched, which is hydrolyzed under a variety of conditions and monitored by LDI-TOF or ESI-MS.